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ABSTRACT
Objectives: The aim of the present study is to assess differences in body composition between female participants in the 
study group who suffer from PCOS versus a healthy control group. 
Material and methods: The study included 85, 14–22-year-old, female participants. Participants belonged to one of two 
groups. Thirty seven participants with a diagnosis of PCOS were in the clinical group, and 48 participants were in the healthy 
control group with no prior diagnosis of PCOS. 
Results: A statistically significant difference between groups was found in their answer regarding diet. A correlation was 
found between the body fat index and the use of dieting among participants; participants with a lower body fat index (in 
kilograms) were less likely to be on a diet. 
Conclusions: The young female participants with PCOS were shown to have similar body composition to age-matched 
healthy controls. However, the clinical group with PCOS reported more frequent use of dieting, with less use of exercise.
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INTRODUCTION
Polycystic ovary syndrome (PCOS) is a heterogeneous 
endocrine disorder that is diagnosed in 3–6% of adolescent 
females. It is estimated that 16% of women who report to 
a gynecological clinic with a menstrual disorder receive 
a final diagnosis of PCOS. The etiology of the syndrome is 
not fully understood; however, it is known that genetics play 
a significance role in determining risk [1, 2].
The most commonly used criteria for the diagnosis of 
polycystic ovary syndrome are The Rotterdam Criteria pro-
posed at the Rotterdam conference with the participation 
of the European Society of Human Reproduction and Em-
bryology (ESHRE) and the American Society of Reproduc-
tion Medicine (ASRM). Determining the diagnosis based 
on these criteria, however, causes difficulties in the group 
of adolescents and women in the perimenopausal period. 
In adolescents, the presence of clinical and biochemical 
symptoms of hyperandrogenism should be particularly 
taken into account. Some of the symptoms that meet the 
criteria for polycystic ovary syndrome may be the result of 
physiological changes in the body of an adolescent woman. 
Therefore, in girls, diagnosis is based modified Rotterdam 
criteria, i.e. all three criteria must be met (and not 2 out of 
3 as for adult women):
1. Oligo- or anovulation (adolescent’s cycle last-
ing > 45 days, or amenorrhea > 90 days);
2. Biochemical exponents of hyperandrogenism or hirsutism;
3. The volume of one of the ovaries > 12 mL or > 24 vesicles 
in the ovary in the ultrasound examination of the pelvis.
Menstrual disorders should be confirmed no earlier 
than two years after the menarche [1–3].
In 2018, the latest recommendations were issued based 
on international evidence-based guidelines for the assess-
ment and management of polycystic ovary syndrome. It was 
found that ultrasound should not be used in the diagnosis 
of PCOS in girls of gynecological age < 8 years (i.e. < 8 years 
after the first menstruation), due to the high incidence of 
polycystic ovaries at this stage of life [4].
Characteristic for PCOS are the coexistence of pre- 
-diabetic conditions (abnormal fasting glucose levels and 
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glucose intolerance), type 2 diabetes, hyperinsulinaemia, 
insulin resistance and obesity. Attention is drawn to the fol-
lowing sequence of events: the results of low birth weight 
are successively: accelerated weight gain, premature 
adrenarche and PCOS. An increase in body mass is most 
likely the key predictor of the severity of the syndrome in 
early puberty. The therapeutic priority for women with PCOS 
is therefore to maintain a normal weight, or lose weight in 
cases where the woman is overweight. Studies show that 
the loss of 10% of one’s body weight at diagnosis aids in the 
return of regular cycles, fertility as well as other metabolic 
parameters; such weight loss also increases insulin sensitiv-
ity in tissues [1, 5–6].
However, the calculation of body mass from a scale does 
not provide any important information about the amount of 
adipose tissue and muscle in the body or the overall hydra-
tion and condition of the body. As such, body mass index 
(BMI) is not a sufficient measure to determine the efficiency 
of human metabolism. In turn, a body composition analysis 
using the bioimpedance method can generate this criti-
cal information. The bioimpedance analysis (BIA) measures 
the impedance (the type of resistance) of tissues through 
low-voltage electric current [7].
Objectives
The aim of the present study is to assess differences in 
body composition between female participants in the study 
group who suffer from PCOS versus a healthy control group. 
The plan is to evaluate the individual body mass elements in 
association with the level of Anti-Mullerian Hormone (AMH) 
and leptin, in an attempt to determine whether lifestyle has 
an effect on the body composition of females diagnosed 
with PCOS versus healthy controls.
MATERIAL AND METHODS
Participants
The study included 85, 14–22-year-old, recruits. Partici-
pants belonged to one of two groups. Thirty seven partici-
pants with a diagnosis of PCOS were in the clinical group, 
and 48 participants were in the healthy control group with 
no prior diagnosis of PCOS. The female participants were 
patients recruited from the Department of Pediatric En-
docrinology of the Upper Silesian Children’s Health Center 
John Paul II in Katowice.
Inclusion criteria for all participants in the study in-
cluded the following: being 14–22 years old and having 
experienced menarche for at least two years prior to the 
study. Exclusion criteria included the use of any pharma-
cotherapy (e.g., hormonal therapy, contraceptives, NSAIDs) 
and the presence of any systemic disease (e.g., cardiovas-
cular disease, diabetes, endocrine disease, autoimmune 
disorders). Participants included in the clinical group were 
rated according to the Rotterdam Criteria (3/3 criteria) to 
determine the presence of PCOS. Only women who for-
mally consented to participate in the study, or girls whose 
guardians consented to their participation, were included 
in the study.
All participants in the study were informed, in detail, 
about the purpose and methodology. Consent was ob-
tained from all participants. Ethics approval for the study 
was obtained from the Bioethical Commission of the Medical 
University of Silesia in Katowice. Throughout the implemen-
tation of the research, researchers strictly abided by the 
ethical principles outlined in the Declaration of Helsinki.
Methods
Participants were required to answer background ques-
tions about their demographics, gynecological history, gen-
eral medical history including relevant diseases, and lifestyle 
using the HBSC Questionnaire — a mandatory, standardized 
questionnaire in Poland in 2013/2014. HBSC is an inter-
national study on the health behavior of school children, 
which are carried out periodically. The questionnaire con-
sists of mandatory questions used by all countries, as well 
as optional questions. The following indicators were used: 
meals, physical activity, dietary habits, self-esteem. Based 
on participant medical history, the length of the menstrual 
cycle was determined. A regular menstrual cycle (eumenor-
rhea) was defined as one that cycled every 21–45 days with 
a length of menstrual bleeding of 3–7 days, and an esti-
mated blood loss of 5–80 mL.
Subsequently, anthropometric measurements (i.e., 
height, weight, and BMI) were taken for each participant. 
The measurements were performed in the morning after 
overnight fasting. The weight (without shoes, in light cloth-
ing) was measured using the RADWAG certified electronic 
scale. The height (in an upright standing position, without 
shoes) was measured using a stadiometer. The weight was 
obtained with an accuracy of 0.1 kg, while the height was 
obtained with an accuracy of 0.5 cm.
The body composition analysis was performed with the 
use of the BodystatQuadscan 4000. The measurement was 
performed 10 minutes after obtaining the supine position. 
The electrodes in accordance to the tetra polar system were 
placed in the mid-dorsal line of the hands and feet.
The intensity of participants’ hirsutism was assessed in 
accordance with the Ferriman–Gallwey score (the quantita-
tive assessment of body hair in nine different parts of the 
body: upper lip, chin, upper and lower abdomen, chest, 
upper arms, as well as thighs, upper and lower back). The 
severity of hirsutism in each part of the body was rated on 
a scale from 0 to 4 points. Hirsutism was diagnosed with 
a score of 8 or more. A transvaginal ultrasound of the pelvis 
was performed on sexually active women and a transab-
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dominal ultrasound (with a full bladder) was performed on 
not sexually active women.
Subsequently, a series of laboratory procedures were 
completed. The blood was collected in the morning after 
overnight fasting, between the 2nd and the 5th day of the 
cycle in the early follicular phase of the menstrual cycle. Then 
the level of total and free testosterone, androstenedione, 
leptin, AMH in serum, insulin, glucose, and the mathematical 
model of insulin resistance HOMA-IR were measured. Insulin 
resistance was diagnosed at HOMA-IR ≥ 2.5. 
The diagnosis of PCOS was made based on the crite-
ria set by the European Society for Human Reproduction 
(ESHRE) and the American Society of Reproductive Medicine 
(ASRM): 1) oligoovulation or anovulation occurred at least 
2 years after the menarche), 2) biochemical exponents of 
hyperandrogenism and hirsutism, 3) the volume of one of 
the ovaries > 12 mL in a pelvic ultrasound scan. PCOS in the 
clinical group of participants was recognized if all of the 
three criteria were met.
RESULTS
The healthy control and clinical groups were compared 
on the variables investigated in this study. The mean age of 
female participants in the clinical group was 19.4 ± 2.4 years, 
while the mean age of participants in the control group was 
20.0 ± 2.2 years. The groups were matched on age, with no 
significant difference between them (p = 0.32). Also there 
were no significant differences between groups on meas-
ures of weight, height and BMI (Tab. 1). 
A statistically significant difference between groups 
was found in their answer regarding diet (p = 0.02). When 
asked, “Are you following any diet or doing anything to lose 
your weight?”, 54.7% of participants in the control group an-
swered that they did not need to adhere to any specific diet 
because their weight is where it is supposed to be, whereas 
only 21.21% of participants in the clinical group answered 
in this way. In the clinical group, 27.27% of participants 
reported that they currently use or have used in the past 
some dietary plan, while only 14.29% of participants in the 
control group provided this answer. However, no statistical 
significance was found between the quality of the meals 
that each group consumed. The girls from both groups 
consumed fruits and vegetables as well as sweets and sweet 
drinks with equal frequency. The results of this analysis are 
presented in Table 2. The participants in the clinical group 
reported significantly less engagement in sports, defined as 
participation in physical activity lasting at least 60 minutes 
per week (p = 0.02). There was no statistical significance 
between the self-assessment measure of participants in the 
control versus clinical group in terms of physical appearance 
(Fig. 1). Furthermore, when asked about the number of hours 
spent watching movies, playing games, using computers 
and social networks during their free time, there were no 
significant differences between groups in their answers. 
Table 3 presents the distribution of individual body mass 
components in the clinical versus control groups. An associa-
tion was noted between the leptin level and body composi-
tion. A statistically significant correlation was found between 
the mass of adipose tissue (described in kilograms and 
percentage) and the content of water in the body (Tab. 4). 
Table 1. Basic characteristic of anthropometric measurements 
amongst the study and control group
Statistical 
parameter
Study group 
[average ± SD]
Control group 
[average ± SD]
Mann–Whitney 
U test
Height [cm] 165.9 ± 6.5 165.5 ± 6.1 p = 0.49
Weight [kg] 64.3 ± 12.4 61.8 ± 9.9 p = 0.31
BMI [kg/m2] 23.3 ± 4.1 22.6 ± 3.5 p = 0.55
BMI — body mass index
Table 2. The frequency of consumption of particular products by females from the test and control groups
Products 
Frequency of 
consumption
Fruits Vegetables Sweets (candy, chocolate)
Coca-cola or other sweet 
drinks
Study 
group
Control 
group
Study 
group
Control 
group
Study 
group
Control 
group
Study 
group
Control 
group
Never 0% 0% 2.94% 0% 2.94% 2.27% 29.41% 22.73%
Less than once a week 6.06% 2.27% 0% 9.09% 11.76% 13.64% 17.65% 47.73%
Once a week 21.21% 15.91% 0% 9.09% 17.65% 13.64% 20.59% 15.91%
2–4 days a week 18.18% 36.36% 41.18% 20.45% 32.35% 34.09% 14.71% 11.36%
5–6 days a week 18.18% 15.91% 20.59% 20.45% 8.82% 11.36% 8.82% 0%
One time every day 18.18% 11.36% 8.82% 22.73% 11.76% 15.91% 2.94% 2.27%
More than once every day 18.18% 18.18% 26.47% 18.18% 14.71% 9.09% 5.88% 0%
Yates’s chi-squared test p = 0.60 p = 0.10 p = 0.98 p = 0.10
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Table 4. Leptin level [ng/mL] in association with the body mass components amongst the study and control groups
Body mass 
component Category
Study group Control group
Average ± standard 
deviation. U Mann-Whitney test
Average ± standard 
deviation U Mann-Whitney test
Body fat index [%]
Below the norm 8.11
p = 0.008
4.98 ± 2.96
p = 0.004Norm 6.20 ± 2.84 9.11 ± 6.30
Above the norm 16.40 ± 11.18 16.90 ± 16.04
Body fat [kg]
Below the norm 8.11
p = 0.03
5.54 ± 2.23
p = 0.001*Norm 6.39 ± 3.13 10.65 ± 6.69
Above the norm 15.92 ± 11.17 16.78 ± 16.14
FFM [kg]
Below the norm 19.14 ± 17.40
p = 0.61
10.00 ± 6.73
p = 0.07Norm 12.67 ± 8.19 15.93 ± 16.30
Above the norm — —
Water content [%]
Below the norm 16.40 ± 11.18
p = 0.006
17.46 ± 16.53
p = 0.003Norm 6.47 ± 2.69 8.89 ± 6.06
Above the norm — 7.07
Water content [kg] Below the norm 16.40 ± 11.18 p = 0.006 17.10 ± 16.30 p = 0.003
*Kruskal–Wallis H test was applied to 3 categories; FFM — fat-free mass
However, there was no correlation between the level of 
AMH and individual body mass components. See Table 5 for 
findings.
A correlation was found between the body fat index 
and the use of dieting among participants; participants with 
a lower body fat index (in kilograms) were less likely to be on 
Table 3. Distribution of body mass components amongst the study and control groups
Body mass 
components
Study group Control group Chi-squared 
testBelow the norm Norm Above the norm Below the norm Norm Above the norm
Body fat index [%] 1 (3.45%) 6 (20.69%) 22 (75.86%) 2 (4.26%) 18 (38.30%) 27 (57.45%) p = 0.28
Body fat [kg] 1 (3.45%) 5 (17.24%) 23 (79.31%) 7 (14.89%) 13 (27.66%) 27 (57.45%) p = 0.15
FFM [kg] 6 (20.69%) 23 (79.31%) 0 (0.00%) 20 (42.55%) 27 (57.45%) 0 (0.00%) p = 0.06
Water content [%] 22 (75.86%) 7 (24.14%) 0 (0.00%) 25 (53.19%) 21 (44.68%) 1 (2.13%) p = 0.17
Water content [kg] 22 (75.86%) 7 (24.14%) 0 (0.00%) 26 (55.32%) 20 (42.55%) 1 (2.13%) p = 0.23
FFM — fat-free mass
% n
50%
0%
Study group (n = 33) Control group (n = 44)
Denitely
underweight
Somewhat
underweight
Self-assessment of appearance of respondents
Acceptable
weight
Somewhat
overweight
Denitely
overweight
39.39% 40.91%
18.18%
6.82%
Test CHI2: NS (p = 0.49)
0.00% 2.27% 2.27%6.06%
36.36%
47.73%
Figure 1. Self-assessment of appearance among study and control groups of females
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a diet (Fig. 2). The same association was found between the 
measure of Fat-free mass (FFM) and the likelihood of being 
on a diet (Fig. 3). Finally, participants with a higher body fat 
index were more likely to see themselves as ‘somewhat, or 
definitely too fat’ (Fig. 4).
DISCUSSION
The incidence of PCOS increases rapidly between 12 and 
14 years of age, peaking between 15 and 24 years of age 
and gradually decreasing until the individual reaches meno-
pause. For this reason, research in this area with young 
females is so important. It appears that research on the 
etiopathogenesis of PCOS, which remains unclear, should 
focus on this age group [8].
Table 5. Spearman’s correlationof the body mass componentswith 
the value of AMH among the study and control groups
Correlations
AMH
Study group Control group
Body fat index [%] R = –0.16p = 0.40
R = –0.08
p = 0.61
Body fat [kg] R = –0.24p = 0.21
R = 0.03
p = 0.87
FFM [kg] R = 0.08p = 0.68
R = 0.08
p = 0.61
Water content [%] R = 0.10p = 0.60
R = –0.01
p = 0.95
Water content [kg] R = –0.10 p = 0.59
R = 0.0
p = 0.91
FFM — fat-free mass
Figure 2. Correlation between body fat index (kg) and current diet among study and control groups
Being on a diet
1 — no, my weight is where it is supposed to be; 2 — no, but I should lose some weight;
3 — no, because I should gain some weight; 4 — yes
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Figure 3. Correlation betweenFat-free mass (kg) and current diet among study and control groups
Being on a diet
1 — no, my weight is where it is supposed to be; 2 — no, but I should lose some weight;
3 — no, because I should gain some weight; 4 — yes; FFM — fat-free mass
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The common features of PCOS, including as hyperinsuli-
naemia, metabolic dysfunction and hyperandrogenemia, are 
associated with the accumulation of excess adipose tissue. 
Regardless of BMI, adipose tissue distribution along with 
proportionately greater abdominal obesity may further ex-
acerbate metabolic abnormalities associated with PCOS [9].
Our study did not show statistically significant differences 
between the body mass composition of female participants 
in a healthy control versus clinical group (participants diag-
nosed with PCOS). The absence of a statistically significant 
difference in the body mass composition between healthy 
and clinical groups of women, measured using the bioim-
pedance method, was previously reported by Geronikolou 
et al. [10]. Furthermore, Attlee et al. [11] used BIA analysis to 
discover that FFM and percentage of adipose tissue did not 
significantly differ between young females with and without 
PCOS. This finding expands on other studies that did not find 
a difference between anthropometric measurements includ-
ing weight, BMI, waist and hip circumference, in women with 
PCOS versus women without PCOS [12]. In turn, Ezeh et al. [13] 
studied a group of adult female patients with PCOS and found 
an unfavorable body composition, characterized by an in-
creased fat-to-muscle ratio. In the studies comparing only BMI 
between groups, women with PCOS had a significantly higher 
BMI compared to the control group (without PCOS) [14].
According to the research, 30–70% of the population 
around the world with PCOS is overweight or obese [15]. The 
increasing number of metabolic and reproductive dysfunc-
tionsassociated with adipose tissue disorders, such as altered 
cytokine secretion, chronic low grade inflammation and oxida-
tive stress, is related to an increased occurrence of PCOS [15].
Adipose tissue is not only the body’s energy storage but 
also the largest endocrine and paracrine organ that synthe-
sizes the biologically active substances. These substances 
are called adipokines and they act both at autocrine/par-
acrine and at endocrine levels. One of these adipokines is 
called leptin. The concentration of the leptin in plasma is di-
rectly proportional to the amount of adipose tissue. In obese 
individuals, prolonged existence of high concentrations of 
leptin leads to leptin resistance and, as a consequence, to in-
creased resistance of peripheral tissues to insulin. According 
to some studies, concentrations of leptin in young females 
with PCOS are directly proportional to BMI, body fat index, 
waist circumference and HOMA-IR index, and are higher 
than those in healthy young females. Our study confirmed 
that the relation between leptin and body fat index exists in 
both the clinical and control groups. It is commonly believed 
that the concentration of leptin in the plasma of young 
females is a determining factor in the onset of puberty. The 
delay in puberty onset in females with low body fat index 
and the occurrence of secondary amenorrhea are most likely 
associated with a decrease in leptin levels [16–19].
It has been found that lifestyle changes can improve 
body mass composition, symptoms of hyperandrogenism 
and insulin resistance in women with PCOS, although there 
is no evidence of a positive effect of these changes on the 
glycemic profile and lipid profile in participants. Neverthe-
less, lifestyle changes are recommended as a first-line treat-
ment in overweight ad obese adolescents with suspected 
PCOS. In our study, young females from the clinical group 
reported significantly more adherence to a diet and less 
participation in sports. Meanwhile, it was that yoga classes 
Self-assessment of appearance
1 — denitely underweight; 2 — somewhat underweight; 3 — acceptable weight; 
4 — somewhat overweight; 5 — denitely overweight
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Figure 4. Correlation between body fat index (kg) and self-assessment of appearance among study and control groups
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were more effective than conventional physical exercises in 
improving glucose, lipids and insulin values. No difference 
was noted between groups in the time that participants 
reported to use the computer or television. Participants with 
a higher body fat index were more likely to be on a diet, or 
only declared it, across groups [8].
Psychological interventions are also an important con-
sideration in this group of patients. An Endocrine Society 
Clinical Practice Guideline indicate an increased incidence of 
depression and anxiety in women with PCOS. It is suggested 
that women with PCOS be screened for depression and 
anxiety. Obesity was indicated as the main factor causing 
depression and emotional stress among young females with 
PCOS. It is stated that the main psychological and behavioral 
interventions that improve mental health in young female 
with PCOS are: good sleep, lifestyle changes (healthy diet 
and prevention of sedentary lifestyles) and regular exercise. 
These strategies are designed to reduce stress and depres-
sion through, among others, weight loss [8, 20].
One of the limitations of the present study is a small 
sample size in the clinical group. However, due to the oc-
currence of PCOS and the range of age of participants in 
the study, collecting a larger sample size would require 
a much longer time frame. Finally, body mass composition 
was measured using BIA, which is less sensitive and accurate 
than other methods such as DXA or MRI. However, BIA has 
been shown to be significantly more cost-effective and 
provides comparable results. Unfortunately, in the literature 
there are no such studies conducted on a group of young 
PCOS girls regarding body composition and dietary habits.
CONCLUSIONS
The young female participants with PCOS were shown 
to have similar body composition to age-matched healthy 
controls. However, the clinical group with PCOS reported 
more frequent use of dieting, with less use of exercise. There 
is a need for further studies in this area of research with 
a larger sample size in order to confirm these results. Al-
though PCOS is considered primarily to be a gynecological 
condition, it is related to many systems in the human body. 
This can result in an increased risk of infertility, insulin re-
sistance, metabolic syndromes, type 2 diabetes, and other 
health concerns. Therefore, a greater understanding of the 
etiopathogenesis of PCOS is of utmost importance.
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